Popularity #4,958Earnings are out
Aytu BioPharma (AYTU)
Commercializer of prescription medicines for depression, ADHD, and pediatric conditions.
$2.13
vs last close−0.10 (−4.48%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
estimated · in 50 days
EPS estimate
−$0.01
Revenue estimate
$17.2M
Fiscal quarter
Q1 FY27
EPSReportedEstimate
Feb '25May '25Sep '25Nov '25Feb '26Sep '26Sep '26Nov '26
Reported−$0.28$0.20−$2.92−$0.08−$1.05−$0.05$0.21Pending
Estimate−$0.28−$0.17−$0.02−$0.06−$0.26−$0.29−$0.29−$0.01
Surprise0.0%+217.6%−14,500.0%−33.3%−303.8%+82.8%+172.4%—
RevenueReportedEstimate
Feb '25May '25Sep '25Nov '25Feb '26Sep '26Sep '26Nov '26
Reported$16.2M$18.5M$15.1M$13.9M$15.2M$16.1M$16.1MPending
Estimate$15.6M$13.7M$17.9M$12.6M$12.2M$12.3M$12.3M$17.2M
Surprise+4.3%+34.3%−15.5%+10.2%+24.9%+31.2%+31.2%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2027 | $0.16 | — | — |
| Mar 2027 | $0.08 | — | — |
| Dec 2026 | $0.02 | — | — |
| Nov 2026 | −$0.01 | — | — |
| Sep 2026 | −$0.29 | $0.21 | +172.4% |
| Sep 2026 | −$0.29 | −$0.05 | +82.8% |
| Feb 2026 | −$0.26 | −$1.05 | −303.8% |
| Nov 2025 | −$0.06 | −$0.08 | −33.3% |
| Sep 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2027 | $0.16 | — | — | $18.7M | — | — | — |
| Mar 2027 | $0.08 | — | — | $15.0M | — | — | — |
| Dec 2026 | $0.02 | — | — | $19.1M | — | — | — |
| Nov 12, 2026 | −$0.01 | — | — | $17.2M | — | — | — |
| Sep 22, 2026 | −$0.29 | $0.21 | +172.4% | $12.3M | $16.1M | +31.2% | — |
| Sep 22, 2026 | −$0.29 | −$0.05 | +82.8% | $12.3M | $16.1M | +31.2% | — |
| Feb 3, 2026 | −$0.26 | −$1.05 | −303.8% | $12.2M | $15.2M | +24.9% | −10.3% |
| Nov 13, 2025 | −$0.06 | −$0.08 | −33.3% | $12.6M | $13.9M | +10.2% | +1.5% |
| Sep 23, 2025 | |||||||
| May 14, 2025 | |||||||
| Feb 12, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Sep 26, 2024 | |||||||
| May 15, 2024 | |||||||
| Feb 14, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Sep 27, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 21, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Sep 27, 2022 | |||||||
| May 16, 2022 | |||||||
| Feb 14, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Sep 27, 2021 | |||||||
| May 17, 2021 | |||||||
| Feb 11, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Oct 6, 2020 | |||||||
| May 14, 2020 | |||||||
| Feb 13, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Sep 26, 2019 | |||||||
| May 14, 2019 | |||||||
| Feb 7, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Sep 6, 2018 | |||||||
| May 14, 2018 | |||||||
| Feb 8, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 31, 2017 | |||||||
| May 11, 2017 | |||||||
| Feb 9, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Sep 1, 2016 | |||||||
| May 4, 2016 | |||||||
| Feb 11, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Sep 30, 2015 |